Atlas Trials

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

Clinical trial NCT01380756 · COMPLETED

Trial details

NCT number
NCT01380756
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
CancerHematologic MalignanciesLeukemiaMyeloid Leukemia
Start date
2011-10-04
Primary completion
2014-09-04
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.